Fierce Biotech April 19, 2024
Max Bayer, Gabrielle Masson

Welcome to this week’s Chutes & Ladders, our roundup of hirings, firings and retirings throughout the industry. Please send the good word—or the bad—from your shop to Max Bayer or Gabrielle Masson, and we will feature it here at the end of each week.

Recursion makes big executive splash, plucking J&J’s chief data science officer

Recursion Pharmaceuticals

AI-infused drug developer Recursion Pharmaceuticals has hired Najat Khan, Ph.D., as chief commercial officer and head of R&D. She joins from Johnson & Johnson where she was chief data science officer and head of strategy and portfolio within the pharma R&D team.

It’s a major hire for the Utah-based biotech, indicative of the rising influence of artificial intelligence and machine learning...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
Pepper Bio spices up pipeline with $135M deal for G1 Therapeutics' CDK4/6 inhibitor
BIO survey to elucidate US biopharma's reliance on Chinese CDMOs amid decoupling threats
Lilly uses Mounjaro millions to hunt for biotech partners
FTC cracks down on drug patents
Methods To Alter Cellular Gene Expression

Share This Article